Texas Grants $5.6 Million to Expand Nursing Education and Workforce Capacity

Translate to Spanish or other 102 languages!

The awards fund innovative prelicensure educational programs for nursing students and expand healthcare workforce capacity across the state. Image for illustration purposes
The awards fund innovative prelicensure educational programs for nursing students and expand healthcare workforce capacity across the state. Image for illustration purposes
- Advertisement -

AUSTIN – Governor Greg Abbott announced more than $5.6 million in grants to eight Texas colleges and universities. The Nursing Innovation Grant Program (NIGP) supports new and expanded projects that improve or extend nursing programs. The awards fund innovative prelicensure educational programs for nursing students and expand healthcare workforce capacity across the state.

“Texas builds the healthcare workforce of tomorrow with strategic investments in nursing education,” said Governor Abbott. “These grants fund innovative programs that prepare more nurses for service in communities across the state. A robust pipeline of well-trained nurses strengthens patient care across Texas and delivers the skilled professionals our communities need.” 

“Providing quality healthcare and increasing access to care require a strong infrastructure of education for nurses and other medical professionals,” said Higher Education Commissioner Wynn Rosser. “Grants from the NIGP contribute to that framework by encouraging and funding new approaches and flexibility in existing programs.”

- Advertisement -

Funded projects may include development of new competency-based nursing curricula, addition of clinical sites or preceptors, or creation of pathways in nursing education. The program also supports stackable credentials for multiple nursing roles, from certificates for nursing aides through baccalaureate degrees in nursing.

Governor Abbott and the Texas Legislature created the NIGP in 2023 to support innovation in nursing education and provided additional funding in 2025. Eligible projects must align with Texas Board of Nursing Education regulations or seek approval for projects not covered by existing rules.

The Texas Higher Education Coordinating Board manages the NIGP. The 2026 recipients receive funding for the grant period that begins September 1, 2026, and ends August 31, 2028.

2026-2028 NIGP Award Recipients:

- Advertisement -

• Alamo Community College – San Antonio College: $748,736


• Austin Community College: $750,000

• Sam Houston State University: $750,000


• Tarrant County College District: $735,134


• Texas Women’s University: $749,977


• The University of Houston: $750,000


• The University of Texas – Austin: $459,840

• The University of Texas Health Science Center – San Antonio: $716,174

Learn more about the Nursing Innovation Grant Program on the Texas Higher Education Coordinating Board website.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.
- Advertisement -